Literature DB >> 31958979

Marta H Costa1, Mauricio Kunz1, Andrew A Nierenberg2, Thilo Deckersbach2, Michael Berk3,4, Pedro V S Magalhaes1.   

Abstract

Entities:  

Keywords:  STEP-BD; bipolar disorder; clozapine; hospitalization; longitudinal study; olanzapine

Mesh：

Substances：

Year:  2020        PMID： 31958979      PMCID： PMC7385420          DOI： 10.1177/0706743719900460

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN： 0706-7437            Impact factor:   4.356


× No keyword cloud information.
  28 in total

1.  Geographical disparities in prescription practices of lithium and clozapine: a community-based study.

Authors:  H Verdoux; E Pambrun; S Cortaredona; M Coldefy; C Le Neindre; M Tournier; P Verger
Journal:  Acta Psychiatr Scand       Date:  2016-01-30       Impact factor: 6.392

2.  A clinical monitoring form for mood disorders.

Authors:  Gary S Sachs; Constance Guille; Stephanie L McMurrich
Journal:  Bipolar Disord       Date:  2002-10       Impact factor: 6.744

3.  Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital.

Authors:  K N R Chengappa; J Vasile; J Levine; R Ulrich; R Baker; A Gopalani; N Schooler
Journal:  Schizophr Res       Date:  2002-01-01       Impact factor: 4.939

4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

5.  Pharmacological treatment and staging in bipolar disorder: evidence from clinical practice.

Authors:  Pedro D Goi; Joana Bücker; Mireia Vianna-Sulzbach; Adriane R Rosa; Iria Grande; Ines Chendo; Leonardo A Sodré; Marcia Kauer-Sant'Anna; Leonardo Silveira; Mauricio Kunz; Keila M Ceresér; Clarissa S Gama; Raffael Massuda
Journal:  Braz J Psychiatry       Date:  2015-05-12       Impact factor: 2.697

6.  Factors associated with changes in hospitalisation in patients prescribed clozapine.

Authors:  Siobhan H Gee; Sukhwinder S Shergill; David M Taylor
Journal:  J Psychopharmacol       Date:  2016-04-19       Impact factor: 4.153

7.  A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.

Authors:  Herbert Y Meltzer; William V Bobo; Ajanta Roy; Karu Jayathilake; Yuejin Chen; Aygun Ertugrul; A Elif Anil Yağcioğlu; Joyce G Small
Journal:  J Clin Psychiatry       Date:  2008-02       Impact factor: 4.384

8.  Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

Authors:  Herbert Y Meltzer; Larry Alphs; Alan I Green; A Carlo Altamura; Ravi Anand; Alberto Bertoldi; Marc Bourgeois; Guy Chouinard; M Zahur Islam; John Kane; Ranga Krishnan; J P Lindenmayer; Steven Potkin
Journal:  Arch Gen Psychiatry       Date:  2003-01

9.  Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study.

Authors:  Jimmi Nielsen; John M Kane; Christoph U Correll
Journal:  Bipolar Disord       Date:  2012-10-26       Impact factor: 6.744

Review 10.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines.

Authors:  Konstantinos N Fountoulakis; Heinz Grunze; Eduard Vieta; Allan Young; Lakshmi Yatham; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.